Jul. 15, 2021 4:57 PM ET
- DexCom (NASDAQ:DXCM) announces that the U.S. FDA has given clearance for its Dexcom Partner Web APIs.
- Invited third-party developers can now integrate real-time CGM data into their digital health apps and devices.
- The clearance expands connectivity and interoperability of the Dexcom CGM digital ecosystem.
- Several diabetes and digital health companies have been invited to access the real-time APIs and are already in the testing and development phase, including Garmin and Teladoc Health’s Livongo for Diabetes, DexCom said.